Follow European Pharmaceutical Review magazine on Twitter Follow us on Twitter Join us on LinkedIn Join us on LinkedIn Like us on Facebook Like us on Facebook Subscribe to RSS feed Subscribe to RSS feed Sign up for email newsletters Receive our email newsletter

Johnson & Johnson announces settlement with U.S. Department of Justice and U.S. Securities and Exchange Commission

Publication date: 8 April 2011
Author: Johnson & Johnson

Tagged with: ,

Johnson & Johnson (NYSE: JNJ) announced today it will pay $70,006,316 in fines, disgorgement and interest, an amount previously reserved for, in a settlement related to publicly disclosed Foreign Corrupt Practices Act (FCPA) investigations by the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC). The Company hopes to reach a settlement of a related investigation by the U.K. Serious Fraud Office (SFO) in several days.

In 2007, Johnson & Johnson voluntarily disclosed to the DOJ and the SEC that subsidiaries outside the United States were believed to have made improper payments in connection with the sale of medical devices. In the course of comprehensive compliance efforts and reports into the Company, similar issues in additional markets and businesses were identified and brought to the attention of the agencies.

As part of the settlement, Johnson & Johnson has entered into a Deferred Prosecution Agreement (DPA) with the DOJ and a Consent to Final Judgment with the SEC. These agreements reflect the recognition by DOJ and SEC of Johnson & Johnson’s voluntary disclosures and subsequent cooperation, as well as the company’s compliance efforts over the past four years. If the company completes three years of enhanced FCPA compliance undertakings and reporting to the DOJ and the SEC, the charges filed by the DOJ against a subsidiary company will be dismissed.

“More than four years ago, we went to the government to report improper payments and have taken full responsibility for these actions,” said William C. Weldon, Chairman and Chief Executive Officer. “We are deeply disappointed by the unacceptable conduct that led to these violations. We have undertaken significant changes since then to improve our compliance efforts, and we are committed to doing everything we can to ensure this does not occur again.”

Today’s settlement also resolves an investigation of Johnson & Johnson subsidiary companies in the United Nations Oil for Food Program, which was not disclosed by the Company to the DOJ and SEC. A U.N.-commissioned report related to the Oil for Food Program alleged that more than 2,000 companies worldwide acquiesced to the Iraqi government’s demands between 2001 and 2003 that they pay a ten percent fee as a condition of importing humanitarian goods into the country.

Mr. Weldon added, “I know that these actions are not representative of Johnson & Johnson employees around the world who do what is honest and right every day, in the conduct of our business and in service to patients and customers worldwide. We will continue to demonstrate that Johnson & Johnson is a company that embraces responsible corporate behavior.”

Advertisement:

Email newsletter

If you enjoyed this article sign-up to receive our bi-weekly email newsletter:

Leave a Reply

© Russell Publishing Limited, 2010-2012. All rights reserved  |  Website design and development by e-Motive Media  |  Terms & conditions of use  |  Privacy policy